Inactivation by osmotic dehydration and air drying of Salmonella, Shiga toxin-producing Escherichia coli, Listeria monocytogenes, hepatitis A virus and selected surrogates on blueberries.

Osmotically dehydrated and air dried berry fruits are used as elements for the manufacturing of yoghurts, goodies, cereal bars and mixes, ice lotions and desserts and these fruits are sometimes subjected to gentle thermal therapies solely, posing questions round their microbiological security.

As osmotic dehydration strategies and parameters range significantly throughout the trade and minimally processed top quality fruits are more and more sought, the scope of this research was to find out which temperatures are required for the inactivation of related micro organism and viruses throughout osmotic dehydration of berries, utilizing blueberries as a mannequin berry in a thawed state to imitate frequent industrial practices.

Moreover, we studied the inactivation of osmotic dehydration at 23 °C, generally referred to “chilly infusion” adopted by air drying at 100 °C to find out the microbiological security achieved by this mixed remedy. 4 pathogens (Salmonella enterica, Escherichia coli O157:

H7, Listeria monocytogenes and hepatitis A virus (HAV)) and 5 surrogates (Enterococcus faecium, Escherichia coli P1, Listeria innocua, murine Norovirus (MNV) and bacteriophage MS2) had been inoculated on blueberries and reductions had been measured after totally different remedy mixtures. After osmotic dehydration of bacterial strains at 40 °C no survivors had been detected on blueberries, apart from E. faecium.

Inactivation of the viruses at 45 °C confirmed no survivors for MS2 and imply reductions of 1.5 and three.four log10 median tissue tradition infectious dose (TCID50)/g for HAV and MNV, respectively. Equally, within the sugar resolution at 40 °C, no survivors had been noticed, apart from E. faecium and the three viruses. The mixed course of (osmotic dehydration at 23 °C adopted by air-drying at 100 °C) achieved an >6 log discount of all examined bacterial strains and MS2.

EIF3K Antibody

1-CSB-PA866204ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EIF3K. Recognizes EIF3K from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IP; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IP:1:200-1:2000

EIF3K Antibody

CSB-PA693741-
EUR 402
Description: A polyclonal antibody against EIF3K. Recognizes EIF3K from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

EIF3K Antibody

CSB-PA693741-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against EIF3K. Recognizes EIF3K from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

EIF3K antibody

70R-36346 100 ug
EUR 392.4
Description: Rabbit polyclonal EIF3K antibody

EIF3K antibody

70R-12634 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal EIF3K antibody

EIF3K Antibody

34680-100ul 100ul
EUR 302.4

EIF3K Antibody

34680-50ul 50ul
EUR 224.4

eIF3K antibody

22622-100ul 100ul
EUR 468

EIF3K Antibody

ABD4052 100 ug
EUR 525.6

EIF3K siRNA

20-abx915183
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EIF3K siRNA

20-abx915184
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

pOTB7-EIF3K

PVT18652 2 ug
EUR 277.2

eIF3K Polyclonal Antibody

ABP51246-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of eIF3K from Human, Mouse. This eIF3K antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human eIF3K at AA range: 30-110

eIF3K Polyclonal Antibody

ABP51246-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of eIF3K from Human, Mouse. This eIF3K antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human eIF3K at AA range: 30-110

eIF3K Polyclonal Antibody

ABP51246-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of eIF3K from Human, Mouse. This eIF3K antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human eIF3K at AA range: 30-110

EIF3K Blocking Peptide

DF4052-BP 1mg
EUR 234

EIF3K Conjugated Antibody

C34680 100ul
EUR 476.4

EIF3K cloning plasmid

CSB-CL866204HU-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the EIF3K gene.

anti- EIF3K antibody

FNab02712 100µg
EUR 658.5
Description: Antibody raised against EIF3K

eIF3K Polyclonal Antibody

ES2245-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against eIF3K from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

eIF3K Polyclonal Antibody

ES2245-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against eIF3K from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

Anti-EIF3K Antibody

A07789 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for EIF3K (EIF3K) detection. Tested with WB in Human.

Anti-eIF3K Antibody

A07789-1 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for eIF3K Antibody (EIF3K) detection. Tested with WB in Human, Mouse.

Anti-EIF3K Antibody

A30681 100ul
EUR 476.4
Description: Rabbit Polyclonal EIF3K Antibody. Validated in WB and tested in Human, Mouse.

EIF3K Blocking Peptide

20-abx161607
  • EUR 727.20
  • EUR 1713.60
  • 1 mg
  • 5 mg

EIF3K Rabbit pAb

A9969-100ul 100 ul
EUR 369.6

EIF3K Rabbit pAb

A9969-200ul 200 ul
EUR 550.8

EIF3K Rabbit pAb

A9969-20ul 20 ul
EUR 219.6

EIF3K Rabbit pAb

A9969-50ul 50 ul
EUR 267.6

Anti-EIF3K antibody

PAab02712 100 ug
EUR 463.2

pENTR223-EIF3K vector

PVT11857 2 ug
EUR 364.8

Anti-EIF3K antibody

STJ112010 100 µl
EUR 332.4

Anti-eIF3K antibody

STJ92875 200 µl
EUR 236.4
Description: Rabbit polyclonal to eIF3K.

Human EIF3K shRNA Plasmid

20-abx959085
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse EIF3K shRNA Plasmid

20-abx978028
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

EIF3K protein (His tag)

80R-1730 50 ug
EUR 366
Description: Purified recombinant Human EIF3K protein

Human EIF3K ELISA KIT

ELI-32671h 96 Tests
EUR 988.8

Bovine EIF3K ELISA KIT

ELI-08650b 96 Tests
EUR 1113.6

Mouse Eif3k ELISA KIT

ELI-10000m 96 Tests
EUR 1038

EIF3K ELISA KIT|Human

EF009346 96 Tests
EUR 826.8

eIF3k Recombinant Protein (Mouse)

RP131297 100 ug Ask for price

eIF3k Recombinant Protein (Rat)

RP199370 100 ug Ask for price

eIF3k Recombinant Protein (Human)

RP010423 100 ug Ask for price

Polyclonal EIF3K Antibody (C-term)

AMM05865G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EIF3K (C-term). This antibody is tested and proven to work in the following applications:

Eif3k ORF Vector (Rat) (pORF)

ORF066458 1.0 ug DNA
EUR 607.2

EIF3K ORF Vector (Human) (pORF)

ORF003475 1.0 ug DNA
EUR 114

Eif3k ORF Vector (Mouse) (pORF)

ORF043767 1.0 ug DNA
EUR 607.2

EIF3K sgRNA CRISPR Lentivector set (Human)

K0668501 3 x 1.0 ug
EUR 406.8

Eif3k sgRNA CRISPR Lentivector set (Rat)

K6347101 3 x 1.0 ug
EUR 406.8

Eif3k sgRNA CRISPR Lentivector set (Mouse)

K4858401 3 x 1.0 ug
EUR 406.8

EIF3K sgRNA CRISPR Lentivector (Human) (Target 1)

K0668502 1.0 ug DNA
EUR 184.8

EIF3K sgRNA CRISPR Lentivector (Human) (Target 2)

K0668503 1.0 ug DNA
EUR 184.8

EIF3K sgRNA CRISPR Lentivector (Human) (Target 3)

K0668504 1.0 ug DNA
EUR 184.8

Eif3k sgRNA CRISPR Lentivector (Rat) (Target 1)

K6347102 1.0 ug DNA
EUR 184.8

Eif3k sgRNA CRISPR Lentivector (Rat) (Target 2)

K6347103 1.0 ug DNA
EUR 184.8

Eif3k sgRNA CRISPR Lentivector (Rat) (Target 3)

K6347104 1.0 ug DNA
EUR 184.8

Eif3k sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4858402 1.0 ug DNA
EUR 184.8

Eif3k sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4858403 1.0 ug DNA
EUR 184.8

Eif3k sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4858404 1.0 ug DNA
EUR 184.8

eIF3k Protein Vector (Human) (pPB-C-His)

PV013897 500 ng
EUR 394.8

eIF3k Protein Vector (Human) (pPB-N-His)

PV013898 500 ng
EUR 394.8

eIF3k Protein Vector (Human) (pPM-C-HA)

PV013899 500 ng
EUR 394.8

eIF3k Protein Vector (Human) (pPM-C-His)

PV013900 500 ng
EUR 394.8

eIF3k Protein Vector (Mouse) (pPB-C-His)

PV175066 500 ng
EUR 723.6

eIF3k Protein Vector (Mouse) (pPB-N-His)

PV175067 500 ng
EUR 723.6

eIF3k Protein Vector (Mouse) (pPM-C-HA)

PV175068 500 ng
EUR 723.6

eIF3k Protein Vector (Mouse) (pPM-C-His)

PV175069 500 ng
EUR 723.6

Recombinant Human EIF3K Protein, His, E.coli-10ug

QP11769-10ug 10ug
EUR 241.2

Recombinant Human EIF3K Protein, His, E.coli-1mg

QP11769-1mg 1mg
EUR 6301.2

Recombinant Human EIF3K Protein, His, E.coli-2ug

QP11769-2ug 2ug
EUR 186

eIF3k Protein Vector (Rat) (pPB-C-His)

PV265830 500 ng
EUR 723.6

eIF3k Protein Vector (Rat) (pPB-N-His)

PV265831 500 ng
EUR 723.6

eIF3k Protein Vector (Rat) (pPM-C-HA)

PV265832 500 ng
EUR 723.6

eIF3k Protein Vector (Rat) (pPM-C-His)

PV265833 500 ng
EUR 723.6

EIF3K 3'UTR Luciferase Stable Cell Line

TU006747 1.0 ml
EUR 1672.8

Eif3k 3'UTR Luciferase Stable Cell Line

TU203890 1.0 ml Ask for price

Eif3k 3'UTR GFP Stable Cell Line

TU253890 1.0 ml Ask for price

Eif3k 3'UTR GFP Stable Cell Line

TU155723 1.0 ml Ask for price

Eif3k 3'UTR Luciferase Stable Cell Line

TU105723 1.0 ml Ask for price

EIF3K 3'UTR GFP Stable Cell Line

TU056747 1.0 ml
EUR 1672.8

Human Eukaryotic translation initiation factor 3 subunit K (EIF3K)

1-CSB-EP866204HU
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Eukaryotic translation initiation factor 3 subunit K(EIF3K) expressed in E.coli

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

20-abx121897
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

abx122816-100ug 100 ug
EUR 469.2

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

20-abx135889
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

20-abx014467
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

abx029064-400ul 400 ul
EUR 627.6

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

abx029064-80l 80 µl
EUR 343.2

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

abx232712-100ug 100 ug
EUR 610.8

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

abx330943-100ul 100 ul
EUR 510

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

20-abx321399
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody

20-abx325584
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

EIF3K Eukaryotic Translation Initiation Factor 3K Human Recombinant Protein

PROTQ9UBQ5 Regular: 10ug
EUR 380.4
Description: EIF3K produced in E.Coli is a single, non-glycosylated polypeptide chain containing 238 amino acids (1-218a.a.) and having a molecular mass of 27.2 kDa. ;EIF3K is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant Aspergillus Clavatus EIF3K Protein (aa 1-249) [His]

VAng-Wyb3769-1mg 1 mg
EUR 5046
Description: Aspergillus Clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1) Eukaryotic Translation Initiation Factor 3 Subunit K, recombinant protein.

EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0668505 3 x 1.0 ug
EUR 451.2

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6347105 3 x 1.0 ug
EUR 451.2

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4858405 3 x 1.0 ug
EUR 451.2

Human Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) ELISA Kit

abx387100-96tests 96 tests
EUR 1093.2

EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0668506 1.0 ug DNA
EUR 200.4

EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0668507 1.0 ug DNA
EUR 200.4

EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0668508 1.0 ug DNA
EUR 200.4

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6347106 1.0 ug DNA
EUR 200.4

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6347107 1.0 ug DNA
EUR 200.4

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6347108 1.0 ug DNA
EUR 200.4

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K4858406 1.0 ug DNA
EUR 200.4

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K4858407 1.0 ug DNA
EUR 200.4

Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K4858408 1.0 ug DNA
EUR 200.4

For HAV and MNV, 2.6 and >3.four log10 TCID50/g had been measured. In abstract, the current research exhibits that osmotic dehydration seems an environment friendly management measure for the management of L. monocytogenes, S. enterica and E. coli O157:H7 if carried out at 40 °C or at 23 °C and adopted by air-drying at 100 °C. Primarily based on the outcomes generated with MNV, the mixed remedy can also be anticipated to scale back human Norovirus (NoV) however doesn’t seem like adequate to totally management HAV.

The outcomes contribute to a greater administration of the microbial security of osmotically dehydrated and dried berries and particularly the outcomes generated for the viruses emphasize that inside a strong meals security administration system, security have to be assured via the complete meals provide chain and due to this fact should begin at main manufacturing with the implementation of Good Agricultural Practices (GAP).

Scroll to Top